T1	Nutrient 29 53	Galacto-oligosaccharides
T2	INCREASES 54 63	Increases
T3	Microorganism 64 78	Bifidobacteria
T4	INCREASES 84 87	Not
T5	Physiology 88 107	Insulin Sensitivity
T6	Population 112 141	ObeseÂ Prediabetic Individuals
T7	Disease 112 117	Obese
T8	Physiology 195 200;213 223	lipid metabolism
T9	Physiology 205 223	glucose metabolism
T10	Physiology 225 232	satiety
T11	Physiology 238 268	chronic low-grade inflammation
T12	Disease 286 293	obesity
T13	Disease 298 313	type 2 diabetes
T14	PREDISPOSES 272 282	contribute
T15	Metabolite 360 382	short-chain fatty acid
T16	Metabolite 384 388	SCFA
T17	Metabolite 390 397	acetate
T18	Nutrient 509 533	galacto-oligosaccharides
T19	Nutrient 535 538	GOS
T21	Nutrient 544 560	acetogenic fiber
T22	Methodology 655 718	double-blinded, placebo-controlled, parallel intervention study
T23	Disease 725 735	overweight
T24	Disease 739 744	obese
T25	Measurement 746 761	body mass index
T26	Population 725 817	overweight or obese (body mass index, 28-40 kg/m2) prediabetic men and women (ages, 45-70 y)
T27	Disease 776 787	prediabetic
T28	Physiology 1277 1299	inflammatory responses
T29	Nutrient 957 960	GOS
T30	Nutrient 984 996	maltodextrin
T31	Physiology 1094 1104;1117 1143	peripheral tissue insulin sensitivity
T32	Physiology 1109 1143	adipose tissue insulin sensitivity
T33	Metabolite 1175 1181;1192 1196	plasma SCFA
T34	Metabolite 1186 1196	fecal SCFA
T35	Physiology 1198 1216	energy expenditure
T36	Physiology 1221 1240	substrate oxidation
T37	Measurement 1242 1258	body composition
T38	Physiology 1264 1272;1290 1299	hormonal responses
T39	Nutrient 1339 1342	GOS
T40	Physiology 1346 1376	peripheral insulin sensitivity
T41	Methodology 1394 1434	hyperinsulinemic-euglycemic clamp method
T42	AFFECTS 1329 1335	effect
T43	Nutrient 1475 1478	GOS
T44	INCREASES 1497 1506	increased
T45	Microorganism 1524 1539	Bifidobacterium
T46	Biospecimen 1551 1556	feces
T47	Biospecimen 1625 1638	fecal samples
T48	Metabolite 1696 1701;1720 1724	fecal SCFA
T49	Metabolite 1705 1724	fasting plasma SCFA
T50	Physiology 1773 1793	gut-derived hormones
T51	Chemical 1795 1804	incretins
T52	Chemical 1806 1840	lipopolysaccharide-binding protein
T53	Measurement 1851 1874	markers of inflammation
T54	AFFECTS 1661 1692	did not observe any differences
T55	AFFECTS 1889 1915	no significant alterations
T56	Physiology 1919 1929;1942 1968	peripheral tissue insulin sensitivity
T57	Physiology 1934 1968	adipose tissue insulin sensitivity
T58	Measurement 1970 1986	body composition
T59	Physiology 1992 1998;2013 2023	energy metabolism
T60	Physiology 2003 2023	substrate metabolism
T61	Nutrient 2080 2083	GOS
T62	INCREASES 2096 2105	increased
T63	Microorganism 2112 2127	Bifidobacterium
T64	AFFECTS 2156 2191	did not produce significant changes
T65	Physiology 2195 2214	insulin sensitivity
T66	Physiology 2240 2257	energy metabolism
T67	Population 2261 2306	overweight or obese prediabetic men and women
T68	Disease 2261 2271	overweight
T69	Disease 2275 2280	obese
T70	Disease 2281 2292	prediabetic
T71	Disease 118 129	Prediabetic
T72	DiversityMetric 1600 1608	richness
T73	AFFECTS 1644 1656	not affected
T74	Physiology 2226 2235;2247 2257	substrate metabolism
T75	DiversityMetric 1612 1621	diversity
E1	INCREASES:T2 Agent:T1 Theme:T3
E2	INCREASES:T4 Agent:T1 Theme:T5
E3	PREDISPOSES:T14 Agent:T11 Theme:T12
E4	PREDISPOSES:T14 Agent:T10 Theme:T12
E5	PREDISPOSES:T14 Agent:T9 Theme:T12
E6	PREDISPOSES:T14 Agent:T8 Theme:T12
E7	PREDISPOSES:T14 Agent:T8 Theme:T13
E8	PREDISPOSES:T14 Agent:T9 Theme:T13
E9	PREDISPOSES:T14 Agent:T11 Theme:T13
E10	PREDISPOSES:T14 Agent:T10 Theme:T13
E11	AFFECTS:T42 Agent:T39 Theme:T40
E12	INCREASES:T44 Agent:T43 Theme:T45
E13	AFFECTS:T54 Agent:T43 Theme:T48
E14	AFFECTS:T54 Agent:T43 Theme:T49
E15	AFFECTS:T54 Agent:T43 Theme:T50
E16	AFFECTS:T54 Agent:T43 Theme:T51
E17	AFFECTS:T54 Agent:T43 Theme:T52
E18	AFFECTS:T54 Agent:T43 Theme:T53
E19	AFFECTS:T55 Agent:T43 Theme:T56
E20	AFFECTS:T55 Agent:T43 Theme:T57
E21	AFFECTS:T55 Agent:T43 Theme:T58
E22	AFFECTS:T55 Agent:T43 Theme:T59
E23	AFFECTS:T55 Agent:T43 Theme:T60
E24	INCREASES:T62 Agent:T61 Theme:T63
E25	AFFECTS:T64 Agent:T61 Theme:T65
E26	AFFECTS:T64 Agent:T61 Theme:T66
E27	AFFECTS:T73 Theme:T72 Agent:T43
E28	AFFECTS:T73 Theme:T75 Agent:T43
A1	Negated E2
A2	Negated E13
A3	Negated E14
A4	Negated E15
A5	Negated E16
A6	Negated E17
A7	Negated E18
A8	Negated E19
A9	Negated E20
A10	Negated E21
A11	Negated E22
A12	Negated E23
A13	Negated E25
A14	Negated E26
A15	Negated E27
A16	Negated E28
N1	CHEBI:24151 T1	galactooligosaccharide
N2	NCBITAXON:1678 T3	Bifidobacterium
N3	OCHV:C0920563 T5	insulin sensitivity
N4	NCIT:C3283 T7	Obesity
N5	NCIT:C19405 T8	Lipid Metabolic Process
N6	OCHV:41587 T9	glucose metabolism
N7	MESH:D012527 T10	Satiation
N8	NCIT:C174450 T11	Chronic Inflammation
N9	NCIT:C3283 T12	Obesity
N10	NCIT:C26747 T13	Type 2 Diabetes Mellitus
N11	CHEBI:26666 T15	short-chain fatty acid
N12	CHEBI:26666 T16	short-chain fatty acid
N13	CHEBI:30089 T17	acetate
N14	CHEBI:24151 T18	galactooligosaccharide
N15	CHEBI:24151 T19	galactooligosaccharide
N16	NCIT:C94250 T23	Overweight
N17	NCIT:C3283 T24	Obesity
N18	NCIT:C16358 T25	Body Mass Index
N19	NCIT:C122685 T27	Prediabetes
N20	NCIT:C20151 T28	Inflammatory Response
N21	CHEBI:24151 T29	galactooligosaccharide
N22	CHEBI:25140 T30	maltodextrin
N23	MESH:D007333 T31	Insulin Resistance
N24	CHEBI:26666 T33	short-chain fatty acid
N25	CHEBI:26666 T34	short-chain fatty acid
N26	NCIT:C147491 T35	Energy Expenditure
N27	MESH:D001823 T37	Body Composition
N28	CHEBI:24151 T39	galactooligosaccharide
N29	MESH:D007333 T40	Insulin Resistance
N30	CHEBI:24151 T43	galactooligosaccharide
N31	NCBITAXON:1678 T45	Bifidobacterium
N32	CHEBI:26666 T48	short-chain fatty acid
N33	CHEBI:26666 T49	short-chain fatty acid
N34	OCHV:C0684155 T50	gut hormone
N35	MESH:D054795 T51	Incretins
N36	NCIT:C105867 T52	Lipopolysaccharide-Binding Protein
N37	MESH:D007333 T56	Insulin Resistance
N38	MESH:D001823 T58	Body Composition
N39	NCIT:C16547 T59	Energy Metabolism Process
N40	CHEBI:24151 T61	galactooligosaccharide
N41	NCBITAXON:1678 T63	Bifidobacterium
N42	OCHV:C0920563 T65	insulin sensitivity
N43	NCIT:C16547 T66	Energy Metabolism Process
N44	NCIT:C94250 T68	Overweight
N45	NCIT:C3283 T69	Obesity
N46	NCIT:C122685 T70	Prediabetes
N47	NCIT:C122685 T71	Prediabetes
A17	Factual E1
A18	Factual E3
A19	Factual E4
A20	Factual E5
A21	Factual E6
A22	Factual E7
A23	Factual E8
A24	Factual E9
A25	Factual E10
A26	Factual E11
A27	Factual E12
A28	Factual E24
